International Journal of Drug Regulatory Affairs (IJDRA)
IJDRA is a broad-spectrum, Open-access & Double blind peer-reviewed official Journal circulated electronically since 2013 via the world wide web. It is the first Journal for Drug Regulatory Affairs in India and it also covers other relevant subjects as Intellectual Property Rights and Pharmaceutical Development and intended to be of interest to a broad audience of pharmaceutical professionals. IJDRA now ideally placed to serve the needs of their Readers, Authors, Technical experts and Advertisers related to the Pharmaceutical field.
Journal ISSN: [Online ISSN: 2321-6794, Print ISSN: 2321-7162]
Publishing Frequency: Quarterly
Submission Type: Online Submission
Copyright License Type: Creative Common Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)
Index Copernicus International (ICV Value): 81.15 points (2016)
Metadata & DOI (doi.org/10.22270/ijdra): From Crossref-Digital Object Identifier Registration Agency.
Journal Indexing: IJDRA Indexed in more than 90 Databases (Highest in subject), See Indexing
UGC approved: UGC Journal No. 45054 (Last update April, 2018)
Publishing System: Open Journal SystemS (OJS) by Public knowledge Project.
1500 INR/article from Indian Authors
USD 30/article from Authors from Low-Income Countries.
USD 40/article from Authors from Low-Middle Income Countries.
USD 60/article from Authors from Upper-Middle-Income Countries
USD 100/article from Authors from High-Income Countries.
(No other hidden charges) More detail for waiver policy.
Upcoming Issue: Vol. 6, Issue 3 July-Sept, 2018. (Last date for Manuscript submission: 31 Aug, 2018)
IJDRA Publishing Group is the member of/Publishing partner of/Source content provider to:-